AI / data analytics / healthtech / informatics

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Elsevier #Research and development #Survey

Report says many R&D companies have based decisions on flawed data

R&D teams are confident in their evidence, yet report making decisions based on flawed or incomplete data, according to Elsevier’s Corporate R&D of the Future report.  The report is based on a global survey of more than 1,000 R&D leaders, managers and researchers at R&D-led corporations. … Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Therapeutic Antibodies

From AI design to experimental validation: The next frontier in antibody discovery

This article is sponsored by GenScript. Integration of artificial intelligence (AI) into antibody drug discovery is occurring in phases, as AI models mature, and developers seek to compress discovery and development timelines. While increasingly iterative and feedback-driven approaches to AI-driven antibody discovery have made the process more efficient, they have… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology

This week in Drug Discovery (26-30 October)

News round-up for 26-30 October 2026 by Megan Thomas, Multimedia Editor at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as four stories that showcase the far reaching impact of artificial intelligence (AI) in drug discovery. The… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Insilico Medicine #Servier

Partnership advances AI-driven R&D collaboration 

Insilico Medicine has achieved the early drug discovery milestone in its multi-year AI-driven drug discovery collaboration with pharmaceutical group Servier.  Under the collaboration, the two companies initiated two distinct R&D programmes for oncology on challenging targets leveraging Insilico’s proprietary end-to-end AI platform, Pharma.AI. Target nominations have been… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Clinical research #Clinical trials #Data standardisation #Drug discovery

The evolution of AI agents in drug discovery

Partha Anbil and Satish Tadikonda explore the current state of AI agents in drug discovery, with a specific focus on clinical data harmonisation, the transition to autonomous laboratories, and the projected market growth that underscores this technological revolution.  Introduction: The dawn of agentic AI  Drug discovery is notoriously protracted, expensive, and fraught… Read More

#Exclusive Content

#AI #AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #FAIR Principles

Building strong data foundations for multimodal drug discovery

As drug discovery spans more modalities and more AI driven workflows, research teams face a growing challenge in keeping data connected and meaningful as it moves between people, systems and organisations. Here, Janice Darlington, Director of Customer Engagement at Collaborative Drug Discovery, explains on behalf of Lab Innovations why strong… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Bioinformatics #Drug discovery #Genomics #QUIAGEN

QIAGEN expands AI-powered bioinformatics for research and drug discovery   

QIAGEN’s new artificial intelligence (AI) capabilities will reportedly help researchers analyse complex biological and genomic data faster while keeping the scientific evidence behind the results visible.  The expansion includes IPA Investigator, a new AI research companion for QIAGEN Ingenuity Pathway Analysis (IPA), and the new QIAGEN Discovery… Read More

#News

AI roadmap
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Investment

AI investment by life science labs hits a four-year high, study finds

The results of a new study show AI/ML investment jumping after three flat years, with three quarters (76%) of respondents planning to increase spending on technology in the next two years, up from 60% in 2023, 62% in 2024, and 63% in 2025.  However, the leading barrier to digital transformation… Read More

#Business & Investment #Editor's Choice #News

Informatics
#AI / data analytics / healthtech / informatics #Drug discovery #eBook

New eBook – Informatics: Transforming data into therapeutics

The global informatics market is expected to triple in size in the next ten years. These technologies are speeding up the process of drug development, but also enabling better accuracy, more precision, more reproducibility and ultimately, better science. This eBook explores the latest developments in artificial… Read More

#News

#AI / data analytics / healthtech / informatics #Bioscience spinout #Contract Research Organisations (CROs) #Durham University #Magnitude Biosciences

Magnitude Biosciences secures £1.3m investment

Magnitude Biosciences, a specialist contract research organisation (CRO) and Durham University spinout, has secured £1.3 million ($1.7 million) in funding to accelerate the commercialisation of VivoScan, its proprietary in vivo high-throughput screening (HTS) platform.   VivoScan is unique in providing HTS for drug discovery in a… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Infectious diseases #Lab automation #Organoids #UK

New robotic AI lab opens in Liverpool to help fight infectious diseases  

The UK’s first high-security robotic AI laboratory designed to accelerate the discovery of drugs and vaccines for infectious diseases has opened in Liverpool.   The £20 million Liverpool Accelerate Laboratory has been developed through the Infection Innovation Consortium: iiCON, which advances pioneering infection R&D through collaboration between industry, researchers and the NHS. It… Read More

#News

Human data concept
#AI / data analytics / healthtech / informatics #Collaboration #GSK #Relation

GSK teams up with Relation to improve disease biology knowledge

Pharmaceutical company GSK has announced a strategic collaboration with the biotech Relation to improve the understanding of disease biology and support the discovery of new therapeutic targets.  Specifically, the partnership will focus on generating large-scale human cellular perturbation data and deploying them into models, such as Relation’s cellular biology foundational… Read More

#Business & Investment #News

Informatics
#AI / data analytics / healthtech / informatics #Drug discovery #Webinar

Webinar: Discover faster, more informed scientific decision-making

In drug discovery, valuable scientific insights are often scattered across spreadsheets, slide decks and email threads. Chemistry teams spend hours preparing for update meetings, chasing CRO progress and digging into the data to find out what has been done before. When hypotheses and learnings only live in slides or individual… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Webinar

Watch on-demand: Real-time chemistry coordination for modern drug discovery

In drug discovery, valuable scientific insights are often scattered across spreadsheets, slide decks and email threads. Chemistry teams spend hours preparing for update meetings, chasing CRO progress and digging into the data to find out what has been done before. When hypotheses and learnings only live in slides or individual… Read More

#News

#AI / data analytics / healthtech / informatics #CNS #Collaboration #Drug discovery

Insilico Medicine and CMS announce CNS disease collaboration 

Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), and China Medical System Holdings has announced an AI‑empowered drug discovery collaboration.   The collaboration is targeting a mass-market indication in central nervous system (CNS) with an innovative mechanism of action (MoA) identified by PandaOmics. According to the collaboration agreement, the two parties will jointly advance the co-development… Read More

#News